BenchSci, a provider of AI solutions for preclinical research and drug discovery, announced a strategic partnership with Thermo Fisher Scientific on September 30th. The partnership will see Thermo Fisher implement BenchSci’s ASCEND AI technology to create new tools to accelerate experimental design and improve R&D productivity. According to a company press release, Thermo Fisher will […]
Post Type Archives: News
PROCOS Selected as Speaker at the Italy Pavilion – Expo 2025 Osaka
PROCOS S.p.A., a leading Italian chemical-pharmaceutical company specializing in the production of active pharmaceutical ingredients (APIs), had the honor of being selected among the speakers at the Italy Pavilion of Expo 2025 Osaka, during the event “Investing in Piemonte presents manufacturing and innovation.” The initiative, organized by the Ministry of Enterprises and Made in Italy […]
OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform
OptymEdge has hired Amy Del Medico as Senior Director, Project Delivery & Transformation, to lead the scale-up and global roll-out of ACUVERA — an integrated, AI-powered suite of technology solutions purpose-built for ophthalmology clinical trials. The platform will be soft-launched at next month’s American Academy of Ophthalmology (AAO) event in Orlando. Del Medico brings more […]
Halozyme to Acquire Elektrofi in $750 Million Deal
Halozyme Therapeutics announced its agreement to acquire Ekeltrofi, a biopharmaceutical formulation technology company, for $750 million. The deal, expected to close in Q4 2025, can reach a total value of $900 million if conditions for three additional milestone payments of $50 million are met. The milestone payments are contingent on regulatory approvals for three separate […]
FDA Approves Novartis’ Chronic Spontaneous Urticaria Treatment
Novartis announced FDA approval of Rhapsido (remibrutinib) as an oral treatment for adult patients with chronic spontaneous urticaria (CSU) who remain symptomatic despite H1 antihistamine treatment. CSU is a condition characterized by red, swollen, and itchy hives, and is thought to be caused by immune dysregulation. According to a company press release, FDA approval was […]
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub
The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub in Gothenburg, Sweden. The partnership aims to leverage the combined expertise of Thermo Fisher and AstraZeneca to drive innovation and strengthen the life science ecosystem. A dedicated team […]
Symeres appoints Gabriella Gentile as Chief Operating Officer to drive transatlantic growth
Symeres, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has appointed Gabriella Gentile as Chief Operating Officer (COO). This strategic addition to the executive team supports Symeres’ transatlantic growth ambitions, building upon its strong foundations in existing and novel modalities. Gabriella brings more than 25 years of international experience in the pharmaceutical, medical […]
NANOFORM EXPANDS COMMERCIAL PRESENCE IN ASIA WITH A&LS PHARMA IN SOUTH KOREA
Nanoform Finland Plc, the medicine performance-enhancing company, today announced it has entered into a distributor agreement with Ageing & Life Science Corp. (“A&LS”), a South Korean pharmaceutical products and services distribution company based in Seoul, South Korea, to bring Nanoform’s cutting-edge nanomedicines and technologies to the country’s pharmaceutical and biotech market. Under the agreement, A&LS […]
Sharp Appoints Samantha Wilson Jones as General Counsel
Sharp Services, a leader in pharmaceutical packaging, clinical trial services & sterile manufacturing, has appointed Samantha Wilson Jones as General Counsel and Corporate Secretary of Sharp. In her role as General Counsel, Samantha will join Sharp’s Senior Leadership Team and report directly to Kevin Orfan, CEO & President. She takes responsibility for Sharp’s legal function […]
Pfizer Strikes Pricing Deal with U.S. Government
Pfizer and the Trump administration have entered into a formal drug pricing agreement aimed at lowering prescription prices for U.S. patients. While the specific terms of the agreement remain confidential, the deal will see Pfizer voluntarily implement measures to lower drug prices for Americans comparable to those available in other developed countries. Newly launched medicines […]